Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Money Forward ( (JP:3994) ) is now available.
Money Forward Consulting, Inc. has completed its tender offer to acquire shares and share acquisition rights of OutlookConsulting Co., Ltd., a Tokyo Stock Exchange Growth Market-listed company, at a price of 1,800 yen per common share and specified prices for two series of share acquisition rights. The offer, launched on November 13, 2025 and closed on January 20, 2026, was structured without a minimum or maximum acceptance threshold, meaning all tendered shares and rights will be purchased, and was designed to raise Money Forward Consulting’s stake by up to 1,011,249 shares, excluding treasury stock. This transaction consolidates Money Forward Consulting’s ownership position in OutlookConsulting and underscores its strategic push to deepen control over a key growth-market affiliate, with implications for future integration, governance alignment, and expansion of its consulting and financial technology ecosystem.
The most recent analyst rating on (JP:3994) stock is a Hold with a Yen5104.00 price target. To see the full list of analyst forecasts on Money Forward stock, see the JP:3994 Stock Forecast page.
More about Money Forward
Money Forward Consulting, Inc. is a Japan-based subsidiary within the Money Forward group, operating in the financial and business consulting domain. From its Tokyo base, the company supports corporate clients with solutions tied to financial management, digital transformation, and related advisory services, leveraging the broader group’s fintech and software platforms to expand its presence in the domestic growth-company segment.
Average Trading Volume: 668,594
Technical Sentiment Signal: Sell
Current Market Cap: Yen246.4B
For detailed information about 3994 stock, go to TipRanks’ Stock Analysis page.

